Home Overview Press Room Blog Publications For Students about us
Search

About Sequencing & Genomics


An organism's genome refers to all the hereditary information encoded in its genes. Sequencing a complete genome, a gene, or a fragment of genetic material involves determining the order of its sub-units: adenine, cytosine, guanine, and thymine.

Scientists are using individuals' genetic sequences to map and catalog human genetic variation in order to improve understanding of human biology, disease susceptibility, and drug response. As costs falls rapidly, the scale and speed of gene sequencing is increasing. The Human Genome Project required thirteen years and $3 billion to sequence the first complete, general human genome. Subsequent projects, such as the International HapMap Project, examined genetic variation between population groups, raising concerns of giving undue biological significance to social categories of race.

Now, the sequencing of complete genomes of specific individuals is becoming almost routine. For example, the Personal Genome Project plans to sequence 100,000 genomes.

Lower prices have also opened the door to companies that offer personal, direct-to-consumer genetic tests.


Poking Holes in Genetic Privacyby Gina KolataThe New York TimesJune 16th, 2013For years now, a steady stream of research has eroded scientists’ faith that DNA can be held anonymously.
After Patent Ruling, Availability of Gene Tests Could Broadenby Andrew PollackThe New York TimesJune 13th, 2013Almost immediately after the Supreme Court ruled that human genes could not be patented, several laboratories announced they, too, would begin offering genetic testing for breast cancer risk.
Reactions to the Supreme Court Ruling Against Myriadby Pete ShanksBiopolitical TimesJune 13th, 2013The unanimous Supreme Court decision that human genes may not be patented was greeted with enthusiasm by the large coalition of plaintiffs and supporters, while the losers tried to put a brave face on it.
Supreme Court Strikes Down Gene Patentsby Pete Shanks and Marcy DarnovskyBiopolitical TimesJune 13th, 2013The Supreme Court's ruling against Myriad Genetics is a triumph for common sense and the common good, and for scientific research and legal fundamentals as well.
Supreme Court Rules Human Genes May Not Be Patentedby Adam LiptakThe New York TimesJune 13th, 2013Isolated human genes may not be patented, the Supreme Court ruled unanimously on Thursday.
The Bleak New World of Prenatal Geneticsby Marcy Darnovsky and Alexandra Minna SternThe Wall Street JournalJune 12th, 2013Like so many other powerful technologies, fetal gene tests must be used with caution and care.
Be Prepared for the Big Genome Leakby Steven E. BrennerNatureJune 12th, 2013Concerns are growing about our ability to properly control access to the information held in genetic research databases.
Size Mattersby Abby Lippman, Biopolitical Times guest contributorJune 11th, 2013Even if there really is a way to use telomere length to predict lifespans, this mirror into our inner workings raises troubling questions.
Should Police Use DNA to Investigate a Suspect’s Family Members?by Nanibaa’ A. Garrison, Rori V. Rohlfs, and Stephanie M. Fullerton, Biopolitical Times guest contributorsJune 11th, 2013A DNA-based technique called familial searching can help police solve serious crimes. It can also be abused in ways that expose innocent people to unwarranted police surveillance.
What Happened When I Had My Genome Sequencedby Carole CadwalladrThe Guardian June 8th, 2013"I was sanguine about having my genome sequenced but maybe that's my faulty risk calculation."
Displaying 1-10 of 567  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760